152 related articles for article (PubMed ID: 10921075)
1. [Study of the molecular mechanism of human cytochrome P450 and genetic polymorphism of drug oxidative metabolizing enzyme].
Zhao L; Lou YQ
Sheng Li Ke Xue Jin Zhan; 1997 Jan; 28(1):35-40. PubMed ID: 10921075
[TBL] [Abstract][Full Text] [Related]
2. Metabolic polymorphisms.
Daly AK; Cholerton S; Gregory W; Idle JR
Pharmacol Ther; 1993; 57(2-3):129-60. PubMed ID: 8361990
[TBL] [Abstract][Full Text] [Related]
3. Bench to bedside: Pharmacogenomics, adverse drug interactions, and the cytochrome P450 system.
Sikka R; Magauran B; Ulrich A; Shannon M
Acad Emerg Med; 2005 Dec; 12(12):1227-35. PubMed ID: 16282513
[TBL] [Abstract][Full Text] [Related]
4. P450 enzymes and Parkinson's disease: the story so far.
Riedl AG; Watts PM; Jenner P; Marsden CD
Mov Disord; 1998 Mar; 13(2):212-20. PubMed ID: 9539332
[TBL] [Abstract][Full Text] [Related]
5. Polymorphism of CYP450 and cancer susceptibility.
Han XM; Zhou HH
Acta Pharmacol Sin; 2000 Aug; 21(8):673-9. PubMed ID: 11501173
[TBL] [Abstract][Full Text] [Related]
6. [Combined effects of genetic polymorphisms in cytochrome P450s and GSTM1 on lung cancer susceptibility].
Gu YF; Zhang ZD; Zhang SC; Zheng SH; Jia HY; Gu SX
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(43):3064-8. PubMed ID: 18261353
[TBL] [Abstract][Full Text] [Related]
7. [Interindividual differences in efficacy and toxicity induced by therapeutic drugs and xenobiotics in relation to genetic polymorphisms in xenobiotic metabolizing enzymes].
Ozawa S
Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 1998; (116):69-81. PubMed ID: 10097514
[TBL] [Abstract][Full Text] [Related]
8. Polymorphism of human cytochrome P450 enzymes and its clinical impact.
Zhou SF; Liu JP; Chowbay B
Drug Metab Rev; 2009; 41(2):89-295. PubMed ID: 19514967
[TBL] [Abstract][Full Text] [Related]
9. Interaction between cytochrome P450 1A2 genetic polymorphism and cigarette smoking on the risk of hepatocellular carcinoma in a Japanese population.
Imaizumi T; Higaki Y; Hara M; Sakamoto T; Horita M; Mizuta T; Eguchi Y; Yasutake T; Ozaki I; Yamamoto K; Onohara S; Kawazoe S; Shigematsu H; Koizumi S; Kudo S; Tanaka K
Carcinogenesis; 2009 Oct; 30(10):1729-34. PubMed ID: 19643819
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphism and toxicology--with emphasis on cytochrome p450.
Johansson I; Ingelman-Sundberg M
Toxicol Sci; 2011 Mar; 120(1):1-13. PubMed ID: 21149643
[TBL] [Abstract][Full Text] [Related]
11. Influence of cytochrome P450 polymorphisms on drug therapies: pharmacogenetic, pharmacoepigenetic and clinical aspects.
Ingelman-Sundberg M; Sim SC; Gomez A; Rodriguez-Antona C
Pharmacol Ther; 2007 Dec; 116(3):496-526. PubMed ID: 18001838
[TBL] [Abstract][Full Text] [Related]
12. Genotyping and phenotyping cytochrome P450: perspectives for cancer treatment.
Mathijssen RH; van Schaik RH
Eur J Cancer; 2006 Jan; 42(2):141-8. PubMed ID: 16325399
[TBL] [Abstract][Full Text] [Related]
13. Genotyping for polymorphisms in xenobiotic metabolism as a predictor of disease susceptibility.
Daly AK; Cholerton S; Armstrong M; Idle JR
Environ Health Perspect; 1994 Nov; 102 Suppl 9(Suppl 9):55-61. PubMed ID: 7698086
[TBL] [Abstract][Full Text] [Related]
14. [Current availability of genetic information of drug metabolizing enzymes, particularly on cytochrome P450(CYP)].
Yamazoe Y; Nagata K
Nihon Rinsho; 2001 Aug; 59(8):1614-23. PubMed ID: 11519169
[TBL] [Abstract][Full Text] [Related]
15. Chapter 21. Additional polymorphisms and cancer.
Stubbins MJ; Wolf CR
IARC Sci Publ; 1999; (148):271-302. PubMed ID: 10493263
[TBL] [Abstract][Full Text] [Related]
16. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects.
Lynch T; Price A
Am Fam Physician; 2007 Aug; 76(3):391-6. PubMed ID: 17708140
[TBL] [Abstract][Full Text] [Related]
17. ABCB1 and cytochrome P450 genotypes and phenotypes: influence on methadone plasma levels and response to treatment.
Crettol S; Déglon JJ; Besson J; Croquette-Krokar M; Hämmig R; Gothuey I; Monnat M; Eap CB
Clin Pharmacol Ther; 2006 Dec; 80(6):668-81. PubMed ID: 17178267
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms in cytochrome P450 genes are associated with an increased risk of squamous cell carcinoma of the larynx and hypopharynx in a Chinese population.
Tai J; Yang M; Ni X; Yu D; Fang J; Tan W; Huang Z; Wu C; Chen X; Wang G; Zhou W; Chen X; Zhang W; Ma L; Lin D; Han D
Cancer Genet Cytogenet; 2010 Jan; 196(1):76-82. PubMed ID: 19963139
[TBL] [Abstract][Full Text] [Related]
19. Review article: The prevalence and clinical relevance of cytochrome P450 polymorphisms.
Wijnen PA; Op den Buijsch RA; Drent M; Kuijpers PM; Neef C; Bast A; Bekers O; Koek GH
Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():211-9. PubMed ID: 18081664
[TBL] [Abstract][Full Text] [Related]
20. Genetic polymorphism of drug metabolizing enzymes: new mutations in CYP2D6 and CYP2A6 genes in Japanese.
Yokoi T; Kamataki T
Pharm Res; 1998 Apr; 15(4):517-24. PubMed ID: 9587945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
